Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus
- PMID: 11884940
- DOI: 10.1097/00007890-200202150-00017
Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus
Abstract
Background: The potential risk of transmission of porcine endogenous retroviruses (PERV) from xenogeneic donors into humans has been widely debated. Because we were involved in a phase I/II clinical trial using a bioartificial liver support system (BLSS), we proceeded to evaluate the biosafety of this device.
Materials and methods: The system being evaluated contains primary porcine hepatocytes freshly isolated from pathogen-free, purpose-raised herd. Isolated hepatocytes were installed in the shell, which is separated by a semipermeable membrane (100-kD nominal cutoff) from the lumen through which the patients' whole blood is circulated. Both before and at defined intervals posthemoperfusion, patients' blood was obtained for screening. Additionally, effluent collected from a clinical bioreactor was analyzed. The presence of viral particles was estimated by reverse transcriptase-polymerase chain reaction (RT-PCR) and RT assays. For the detection of pig genomic and mitochondrial DNA, sequence-specific PCR (SS-PCR) was used. Finally, the presence of infectious viral particles in the samples was ascertained by exposure to the PERV-susceptible human cell line HEK-293.
Results: PERV transcripts, RT activity, and infectious PERV particles were not detected in the luminal effluent of a bioreactor. Culture supernatant from untreated control or mitogen-treated porcine hepatocytes (cleared of cellular debris) also failed to infect HEK-293 cell lines. Finally, RT-PCR, SS-PCR, and PERV-specific RT assay detected no PERV infection in the blood samples obtained from five study patients both before and at various times post-hemoperfusion.
Conclusion: Although longer patient follow-up is required and mandated to unequivocally establish the biosafety of this device and related bioartificial organ systems, these analyses support the conclusion that when used under standard operational conditions, the BLSS is safe.
Similar articles
-
Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor.World J Gastroenterol. 2005 Aug 14;11(30):4727-30. doi: 10.3748/wjg.v11.i30.4727. World J Gastroenterol. 2005. PMID: 16094718 Free PMC article.
-
Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system.World J Gastroenterol. 2006 Feb 28;12(8):1287-91. doi: 10.3748/wjg.v12.i8.1287. World J Gastroenterol. 2006. PMID: 16534887 Free PMC article.
-
Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells.Liver Int. 2009 Nov;29(10):1553-61. doi: 10.1111/j.1478-3231.2009.02087.x. Epub 2009 Aug 14. Liver Int. 2009. PMID: 19686312
-
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses.Xenotransplantation. 2009 Jul-Aug;16(4):239-48. doi: 10.1111/j.1399-3089.2009.00544.x. Xenotransplantation. 2009. PMID: 19799764
-
Detection of porcine endogenous retrovirus in xenotransplantation.Reprod Biol. 2014 Mar;14(1):68-73. doi: 10.1016/j.repbio.2014.01.006. Epub 2014 Feb 5. Reprod Biol. 2014. PMID: 24607257 Review.
Cited by
-
Identification of two distinct structural regions in a human porcine endogenous retrovirus receptor, HuPAR2, contributing to function for viral entry.Retrovirology. 2009 Jan 14;6:3. doi: 10.1186/1742-4690-6-3. Retrovirology. 2009. PMID: 19144196 Free PMC article.
-
Long-term safety from transmission of porcine endogenous retrovirus after pig-to-non-human primate corneal transplantation.Xenotransplantation. 2017 Jul;24(4):10.1111/xen.12314. doi: 10.1111/xen.12314. Epub 2017 May 14. Xenotransplantation. 2017. PMID: 28503733 Free PMC article.
-
Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure.Tissue Eng Part A. 2009 Nov;15(11):3377-88. doi: 10.1089/ten.TEA.2008.0681. Tissue Eng Part A. 2009. PMID: 19397469 Free PMC article.
-
Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.Clin Microbiol Rev. 2012 Apr;25(2):318-43. doi: 10.1128/CMR.05011-11. Clin Microbiol Rev. 2012. PMID: 22491774 Free PMC article. Review.
-
Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor.World J Gastroenterol. 2005 Aug 14;11(30):4727-30. doi: 10.3748/wjg.v11.i30.4727. World J Gastroenterol. 2005. PMID: 16094718 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous